Tatjana Engler - Publications, H-index & Citations

Tatjana Engler

ulm university

13H指数

47论文数

618被引数

收录论文 13

发表时间

An Aptamer-Based gFET-Sensor for Specific Quantification of Gene Therapeutic Human Adenovirus Type 5 基于适配体的gFET传感器，用于特定基因治疗用人类腺病毒5型的定量分析

Biosensors 2025, Vol. 15, Page 605

IF5.6

2025-09-19

OAAI

Runliu Li; Ann-Kathrin Kissmann; Hu Xing; Roger Hasler; Christoph Kleber; Wolfgang Knoll; Hannes Schmietendorf; Tatjana Engler; Lea Krutzke; Stefan Kochanek; Frank Rosenau

Process- and product-related impurities in the ChAdOx1 nCov-19 vaccine

ELIFE

IF0

2022-07-04

OAAI

Krutzke, Lea; Roesler, Reinhild; Allmendinger, Ellen; Engler, Tatjana; Wiese, Sebastian; Kochanek, Stefan

HAP40 protein levels are huntingtin-dependent and decrease in Huntington disease

NEUROBIOLOGY OF DISEASE

IF5.6

2021-10-01

OAAI

Huang, Bin; Seefelder, Manuel; Buck, Eva; Engler, Tatjana; Lindenberg, Katrin S.; Klein, Fabrice; Landwehrmeyer, G. Bernhard; Kochanek, Stefan

HUNTINGTIN-DEPENDENT STABILITY OF HAP40 AND DECREASED HAP40 LEVELS IN HUNTINGTON'S DISEASE

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

IF7.5

2021-09-05

PREAI

Seefelder, Manuel; Huang, Bin; Buck, Eva; Engler, Tatjana; Lindenberg, Katrin S.; Landwehrmeyer, Bernhard; Kochanek, Stefan

THE CRYO-ELECTRON MICROSCOPY STRUCTURE OF HUNTINGTIN

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

IF7.5

2018-09-01

PREAI

Kochanek, Stefan; Huang, Bin; Seefelder, Manuel; Engler, Tatjana; Cheng, Jingdong; Baumeister, Wolfgang; Guo, Qiang; Fernandezt-Busnadiego, Ruben

Shielding of Ad5 by Minimal Geneti-Chemical Modification: Preventing Clearance While Preserving Infectivity

MOLECULAR THERAPY

IF12

2015-05-01

OAAI

Krutzke, Lea; Prill, Jan-Michael; Engler, Tatjana; Hoffmeister, Andrea; Schmidt, Christoph Q.; Xu, Zhili; Byrnes, Andrew P.; Kochanek, Stefan; Kreppel, Florian

High-capacity adenoviral vectors circumvent the limitations of ΔE1 and ΔE1/ΔE3 adenovirus vectors to induce multispecific transgene product-directed CD8 T-cell responses 高容量腺病毒载体规避了 ΔE1和 ΔE1/ΔE3腺病毒载体的局限性，以诱导多特异性转基因产物定向的CD8 T细胞反应

JOURNAL OF GENE MEDICINE

IF2.2

2011-12-22

PREAI

Kron, Matthias W.; Engler, Tatjana; Schmidt, Erika; Schirmbeck, Reinhold; Kochanek, Stefan; Kreppel, Florian

ΔE1 and high-capacity adenoviral vectors expressing full-length codon-optimized merozoite surface protein 1 for vaccination against Plasmodium falciparum

JOURNAL OF GENE MEDICINE

IF2.2

2011-12-22

PREAI

Zong, Shan; Kron, Matthias W.; Epp, Christian; Engler, Tatjana; Bujard, Hermann; Kochanek, Stefan; Kreppel, Florian

miRNA-mediated Silencing in Hepatocytes Can Increase Adaptive Immune Responses to Adenovirus Vector-delivered Transgenic Antigens

MOLECULAR THERAPY

IF12

2011-08-01

OAAI

Kron, Matthias W.; Espenlaub, Sigrid; Engler, Tatjana; Schirmbeck, Reinhold; Kochanek, Stefan; Kreppel, Florian

Modifications of Adenovirus Hexon Allow for Either Hepatocyte Detargeting or Targeting With Potential Evasion From Kupffer Cells

MOLECULAR THERAPY

IF12

2011-01-01

OAAI

Prill, Jan-Michael; Espenlaub, Sigrid; Samen, Ulrike; Engler, Tatjana; Schmidt, Erika; Vetrini, Francesco; Rosewell, Amanda; Grove, Nathan; Palmer, Donna; Ng, Philip; Kochanek, Stefan; Kreppel, Florian

Targeting of Adenovirus Vectors to the LRP Receptor Family With the High-affinity Ligand RAP via Combined Genetic and Chemical Modification of the pIX Capsomere

MOLECULAR THERAPY

IF12

2008-11-01

OAAI

Corjon, Stephanie; Wortmann, Andreas; Engler, Tatjana; van Rooijen, Nico; Kochanek, Stefan; Kreppel, Florian

Reductive amination as a strategy to reduce adenovirus vector promiscuity by chemical capsid modification with large polysaccharides

JOURNAL OF GENE MEDICINE

IF2.2

2008-10-06

PREAI

Espenlaub, Sigrid; Wortmann, Andreas; Engler, Tatjana; Corjon, Stephanie; Kochanek, Stefan; Kreppel, Florian